Home » Topics » Regulatory

Regulatory
RSS

Vita-Invest's combination therapy for hypertension completes phase III

Feb. 23, 2001

Therapeutic agents for drug addiction, withdrawal, etc., claimed by Knoll

Feb. 22, 2001

Protopic for severe atopic dermatitis launched in U.S.

Feb. 20, 2001

Altace approved in Canada for expanded indication

Feb. 20, 2001

Novartis receives FDA approval for Foradil Aerolizer for asthma maintenance therapy

Feb. 20, 2001

FDA advisory committee recommends approval of injectable ziprasidone

Feb. 16, 2001

New oral formulation of Zomig approved by FDA

Feb. 15, 2001

Intramuscular formulation of Zyprexa clears hurdle on the way to FDA approval

Feb. 15, 2001

First oral chemotherapy for treatment of metastatic colorectal cancer approved in Europe

Feb. 12, 2001

Approvable letter issued by FDA for GlaxoSmithKline's Avandia in combination with insulin

Feb. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...